BACKGROUND: To describe the epidemiology and trends of imported malaria in the Netherlands from 2000 through 2007. METHODS: Based on national surveillance data regarding all reported infections of imported malaria, diagnosed 2000 through 2007, incidence and trends of imported malaria in the Netherlands were estimated. Travellers statistics were used to estimate incidence, and data on malaria chemoprophylaxis prescriptions were used to estimate the number of unprotected travellers. RESULTS: Importation of malaria to the Netherlands is declining even as more travellers visit malaria-endemic countries. On average, 82% were acquired in sub-Saharan Africa, and 75% were caused by Plasmodium falciparum. The overall incidence in imported falciparum malaria fell from 21.5 to 6.6/10,000 of unprotected travellers. The percentage of unprotected travellers rose from 47% to 52% of all travellers. The incidence of imported falciparum infections is greatest from Middle and West Africa, and decreased from 121.3 to 36.5/10,000 travellers. The import of malaria from this region by immigrants visiting friends and relatives (VFR) decreased from 138 infections in 2000, to 69 infections in 2007. CONCLUSION: The annual number of imported malaria shows a continuing declining trend, even with an increasing number of travellers visiting malaria endemic countries. VFR import less malaria than previously, and contribute largely to the declining incidence seen. The decline is not readily explained by increased use of chemoprophylaxis and may reflect a reduced risk of infection due to decreasing local malaria transmission as observed in some malaria endemic areas. Nevertheless, the increasing number of unprotected travellers remains worrisome.
BACKGROUND: To describe the epidemiology and trends of imported malaria in the Netherlands from 2000 through 2007. METHODS: Based on national surveillance data regarding all reported infections of imported malaria, diagnosed 2000 through 2007, incidence and trends of imported malaria in the Netherlands were estimated. Travellers statistics were used to estimate incidence, and data on malaria chemoprophylaxis prescriptions were used to estimate the number of unprotected travellers. RESULTS: Importation of malaria to the Netherlands is declining even as more travellers visit malaria-endemic countries. On average, 82% were acquired in sub-Saharan Africa, and 75% were caused by Plasmodium falciparum. The overall incidence in imported falciparum malaria fell from 21.5 to 6.6/10,000 of unprotected travellers. The percentage of unprotected travellers rose from 47% to 52% of all travellers. The incidence of imported falciparum infections is greatest from Middle and West Africa, and decreased from 121.3 to 36.5/10,000 travellers. The import of malaria from this region by immigrants visiting friends and relatives (VFR) decreased from 138 infections in 2000, to 69 infections in 2007. CONCLUSION: The annual number of imported malaria shows a continuing declining trend, even with an increasing number of travellers visiting malaria endemic countries. VFR import less malaria than previously, and contribute largely to the declining incidence seen. The decline is not readily explained by increased use of chemoprophylaxis and may reflect a reduced risk of infection due to decreasing local malaria transmission as observed in some malaria endemic areas. Nevertheless, the increasing number of unprotected travellers remains worrisome.
Authors: T Jelinek; C Schade Larsen; H Siikamäki; B Myrvang; P Chiodini; J Gascon; L Visser; A Kapaun; G Just-Nübling Journal: Euro Surveill Date: 2008-12-18
Authors: B Høgh; P D Clarke; D Camus; H D Nothdurft; D Overbosch; M Günther; I Joubert; K C Kain; D Shaw; N S Roskell; J D Chulay Journal: Lancet Date: 2000-12-02 Impact factor: 79.321
Authors: Vincent Robert; Kate Macintyre; Joseph Keating; Jean-Francois Trape; Jean-Bernard Duchemin; McWilson Warren; John C Beier Journal: Am J Trop Med Hyg Date: 2003-02 Impact factor: 2.345
Authors: Koen Van Herck; Pierre Van Damme; Francesco Castelli; Jane Zuckerman; Hans Nothdurft; Atti-La Dahlgren; Sandra Gisler; Robert Steffen; Panagiotis Gargalianos; Rogelio Lopéz-Vélez; David Overbosch; Eric Caumes; Eric Walker Journal: J Travel Med Date: 2004 Jan-Feb Impact factor: 8.490
Authors: Ron H Behrens; Bernadette Carroll; Jiri Beran; Olivier Bouchaud; Urban Hellgren; Christoph Hatz; Tomas Jelinek; Fabrice Legros; Nikolai Mühlberger; Bjørn Myrvang; Heli Siikamäki; Leo Visser Journal: Malar J Date: 2007-08-23 Impact factor: 2.979
Authors: H Frickmann; N G Schwarz; H-U Holtherm; W Maassen; F Vorderwülbecke; K Erkens; M Fischer; T Morwinsky; R M Hagen Journal: Infection Date: 2013-01-31 Impact factor: 3.553
Authors: Tom van Gool; Marlies E van Wolfswinkel; Rob Koelewijn; Pieter P A M van Thiel; Jan Jacobs; Jaap J van Hellemond; Perry J J van Genderen Journal: Malar J Date: 2011-10-14 Impact factor: 2.979
Authors: Sanne-Meike Belderok; Anneke van den Hoek; Will Roeffen; Robert Sauerwein; Gerard J B Sonder Journal: PLoS One Date: 2013-02-25 Impact factor: 3.240